Johnson and Johnson stock reached a new 52-week high, touching 181.17 USD, underscoring a period of robust performance for the healthcare giant. With a substantial market capitalization of $436 ...
In patients with T2D, the risks for gastroesophageal reflux disease and related complications are greater with GLP-1 RA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback